Zeo ScientifiX (ZEOX) Convertible Debt (2018 - 2025)

Zeo ScientifiX (ZEOX) posted quarterly Convertible Debt of $41667.0 for Q4 2025, down 70.02% quarter-over-quarter from $139000.0 in Q1 2022.

Zeo ScientifiX (ZEOX) Convertible Debt (2018 - 2025) Analysis & Trends

Zeo ScientifiX's Convertible Debt history runs 4 years deep, the most recent figure standing at $41667.0 for Q4 2025.

In Q4 2025, Convertible Debt changed N/A year-over-year to $41667.0; the TTM figure through Oct 2025 stood at $41667.0 (changed N/A YoY), while the FY2025 annual figure was $41667.0, changed N/A from the prior year.
Convertible Debt for Q4 2025 stood at $41667.0, down from $139000.0 in the prior quarter.
The five-year high for Convertible Debt was $139000.0 in Q1 2022, with the low at $41667.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Zeo ScientifiX	11.02 Mn	9.17 Mn	2.06 Mn

Download Data